David P Perry - Net Worth and Insider Trading
David P Perry Net Worth
The estimated net worth of David P Perry is at least $3 Million dollars as of 2024-04-26. David P Perry is the President and CEO of Anacor Pharmaceuticals Inc and owns about 261,154 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $3 Million. David P Perry is also the Executive Chairman, 10% Owner of Better Therapeutics Inc and owns about 17,082,779 shares of Better Therapeutics Inc (BTTX) stock worth over $153,745. Details can be seen in David P Perry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David P Perry has not made any transactions after 2023-07-27 and currently still holds the listed stock(s).
Transaction Summary of David P Perry
David P Perry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David P Perry owns 4 companies in total, including Evelo Biosciences Inc (EVLO) , Anacor Pharmaceuticals Inc (ANAC) , and Better Therapeutics Inc (BTTX) among others .
Click here to see the complete history of David P Perry’s form 4 insider trades.
Insider Ownership Summary of David P Perry
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EVLO | Evelo Biosciences Inc | 2018-05-08 | director |
| ANAC | Anacor Pharmaceuticals Inc | 2014-03-04 | director & President and CEO |
| BTTX | Better Therapeutics Inc | 2023-07-27 | director & 10 percent owner & See Remarks |
| MCADU | Mountain Crest Acquisition Corp II | 2021-10-28 | director & 10 percent owner & See Remarks |
David P Perry Latest Holdings Summary
David P Perry currently owns a total of 2 stocks. Among these stocks, David P Perry owns 261,154 shares of Anacor Pharmaceuticals Inc (ANAC) as of November 23, 2010, with a value of $3 Million and a weighting of 94.34%. David P Perry also owns 17,082,779 shares of Better Therapeutics Inc (BTTX) as of July 27, 2023, with a value of $153,745 and a weighting of 5.66%.
Latest Holdings of David P Perry
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2010-11-23 | 261,154 | 9.82 | 2,564,532 |
| BTTX | Better Therapeutics Inc | 2023-07-27 | 17,082,779 | 0.01 | 153,745 |
Holding Weightings of David P Perry
David P Perry Form 4 Trading Tracker
According to the SEC Form 4 filings, David P Perry has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 0 shares on November 23, 2010, which brought David P Perry around $0.
According to the SEC Form 4 filings, David P Perry has made a total of 4 transactions in Better Therapeutics Inc (BTTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Better Therapeutics Inc is the acquisition of 1,233,045 shares on July 27, 2023, which cost David P Perry around $900,123.
Insider Trading History of David P Perry
- 1
David P Perry Trading Performance
GuruFocus tracks the stock performance after each of David P Perry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David P Perry is -45.95%. GuruFocus also compares David P Perry's trading performance to market benchmark return within the same time period. The performance of stocks bought by David P Perry within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David P Perry's insider trading performs compared to the benchmark.
Performance of David P Perry
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -21.07 | -45.95 | -64.18 | -87.71 | ||
| Relative Return to S&P 500(%) | -17.83 | -45.12 | -69.54 | -107.91 |
David P Perry Ownership Network
Ownership Network List of David P Perry
Ownership Network Relation of David P Perry
David P Perry Owned Company Details
What does Evelo Biosciences Inc do?
Who are the key executives at Evelo Biosciences Inc?
David P Perry is the director of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .
Evelo Biosciences Inc (EVLO) Insider Trades Summary
Over the past 18 months, David P Perry made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 103,730 shares made by Mark Bodmer , a net sale of 80,121 shares made by Duncan Mchale , and a net sale of 46,345 shares made by Marella Thorell .
In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 46,837 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,364,418 shares.
Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evelo Biosciences Inc Insider Transactions
David P Perry Mailing Address
Above is the net worth, insider trading, and ownership report for David P Perry. You might contact David P Perry via mailing address: 1020 East Meadow Circle, Palo Alto Ca 94303.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
